Skip to main content

Clinical Relevance of Blast Cell Phenotype as Determined with Monoclonal Antibodies in Acute Lymphoblastic Leukemia of Adults

  • Conference paper
Acute Leukemias

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 30))

Abstract

Over the past 10 years, leukemias and lymphomas have been analyzed extensively with antibodies and for enzyme activity [1, 2]. More recently, the introduction of monoclonal antibodies (MoAbs) has improved dramatically the precision, practicability, and standardization of immunophenotyping. Meanwhile, immunologic analysis of leukemia cells has become routine clinical practice, and evidence that cell typing with antibodies contributes to final diagnosis, differential diagnosis, and classification of leukemias is compelling [3].

Supported by the Bundesministerium für Forschung und Technologie (BMFT) and by Deutsche Krebshilfe.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Foon KA, Schroff RW, Gale RP (1982) Sur¬face markers on leukemia and lymphoma cells: secent advances. Blood 60: 1 13.

    Google Scholar 

  2. Thiel E (1985) Cell surface markers in leu¬kemia: biological and clinical correlations. CRC Crit Rev Oncol/Hematol 2: 209–259

    Article  CAS  Google Scholar 

  3. Chan LC, Pegram SM, Greaves MF (1985) Contribution of immunophenotype to the classification and differential diagnosis of acute leukemia. Lancet I: 475–479 14.

    Article  Google Scholar 

  4. Greaves MFI, Janossy G, Peto J, Kay H (1981) Immunologically defined subclasses of acute lymphoblastic leukemia in children: their relationship to presentation features and prognosis. Br J Haematol 48: 179–198

    PubMed  CAS  Google Scholar 

  5. Kersey J, Goldman A, Abramson C, Nesbit 15. M, Perry G, Gajl-Peczalska K, LeBien T (1982) Clinical usefulness of monoclonal anti¬body phenotyping in childhood acute lym¬phoblastic leukemia. Lancet II: 1419–1423

    Google Scholar 

  6. Thiel E, Rodt H, Huhn D, Netzel B, Grosse-Wilde H, Ganeshaguru K, Thierfelder S (1980) Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance. Blood 56: 759–772

    PubMed  CAS  Google Scholar 

  7. Thiel E, Kummer U, Rodt H, Stünkel K, Munker R, Knapp W, Thierfelder S (1982) Comparison of currently available monoclo¬nal antibodies with conventional markers for phenotyping of one hundred acute leukemias. Blut 44: 95

    Article  PubMed  CAS  Google Scholar 

  8. IUIS-WHO nomenclature subcommittee on human leukocyte differentiation antigens(1984). Bull WHO:809–811

    Google Scholar 

  9. Moir DJ, Ghosh AK, Abdulaziz Z, Knight PM, Mason DY (1983) Immunoenzymatic staining of haematological samples with monoclonal antibodies. Br J Haematol 55: 395–410

    Article  PubMed  CAS  Google Scholar 

  10. Pezzuto A, Dörken B, Feller A, Moldenhauer G, Schwarz R, Wernet P, Thiel E, Hunstein W (1986) HD37 monoclonal antibody: A use¬ful reagent for further characterization of “non-T/non-B” lymphoid malignancies. In: Reinherz EL, Haynes BF,Nadler LM,Ben-stin JD(eds)Leukocyte typing,vol 2.Springer,Berlin Heidelberg New York Tokyo,pp 391–402

    Google Scholar 

  11. Korsmeyer SJ, Arnold A, Bakkshi A, Ravetch JV, Siebenlist U, Hieter PA, Sharrow SO, LeBien TW, Kersey JH, Poplack DG, Leder P (1983) Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J clin Invest 7: 301–313

    Article  Google Scholar 

  12. Mirro J, Zipf TF, Pui C-H, Kitchingman G, Williams D, Melvin S, Murphy SB, Stass S (1985) Acute mixed lineage leukemia: clinico-pathologic correlations and prognostic significance. Blood 66: 1115–1123

    PubMed  CAS  Google Scholar 

  13. Kita K, Nasu K, Kamesaki H, Doi S, Tezuka H, Tatsumi E, Fukuhara S, Nishikori M, Uchino H, Shirakawa S (1985) Phenotypic analysis of acute lymphoblastic leukemia ( ALL) cells which are classified as non-T non-B and negative for common ALL antigen. Blood 66: 47–52

    Google Scholar 

  14. Sobol RE, Royston I, LeBien TW, Minowada J, Anderson K, Davey FR, Cuttner J, Schiffer, Ellison RR, Bloomfield CD (1985) Adult acute lymphoblastic leukemia phentotypes defined by monoclonal antibodies. Blood 65: 730–735

    PubMed  CAS  Google Scholar 

  15. Maire JP, Perrot JY, Boucheix C, Zittoun J, Martyre MC, Kayibanda M, Rosenfeld C, Mishal Z, Zittoun R (1982) Determination of ultrastructural peroxidases and immunologic membrane markers in the diagnosis of acute leukemias. Blood 59: 270–276

    Google Scholar 

  16. Gregg SL, Gail-Peczalska KJ, LeBien TW, Bloomfield CD, Brunning R, Sagawa K (1984) Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia. Cancer Res 44: 2724–2730

    PubMed  CAS  Google Scholar 

  17. Shkolnik T, Schlossman S, Griffin JD (1985) Acute undifferentiated leukemia: Induction of partial differentiation by phorbol ester. Leuk Res 9: 11–17

    Google Scholar 

  18. Neame PB, Soamboonsrup P, Browman G, Barr RD, Saeed N, Chan B, Pao M, Benger A, Wilson WE, Walker IR, McBride JA (1985) Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. Blood 65: 142–148

    PubMed  CAS  Google Scholar 

  19. Gutensohn W, Thiel E (1985) Ecto-5’-nucleotidase as marker for differential diagnosis in acute undifferentiated leukemia in adults. Blut 51 (Astract): 164

    Google Scholar 

  20. Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H,Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mi-trou PS, Pfreundschuh M, Görg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64: 38–47

    PubMed  CAS  Google Scholar 

  21. Crist W, Pullen J, Boyett J, Falletta J, van Eys J, Borowitz M, Jackson J, Dowell B, Frankel L, Quddus F, Ragab A, Vietti T (1986) Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants:a pediatric oncology group study. Blood 67: 135–140

    PubMed  CAS  Google Scholar 

  22. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgström GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Secker Walker LM, Tricot G, Van Den Berghe H, Van Orshoven A, Vuopio P, Whang-Peng J (1986) Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67: 412–420

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Thiel, E., Hoelzer, D., Dörken, B., Löffler, H., Messerer, C., Huhn, D. (1987). Clinical Relevance of Blast Cell Phenotype as Determined with Monoclonal Antibodies in Acute Lymphoblastic Leukemia of Adults . In: Büchner, T., Schellong, G., Hiddemann, W., Urbanitz, D., Ritter, J. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71213-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71213-5_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16556-9

  • Online ISBN: 978-3-642-71213-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics